<DOC>
	<DOCNO>NCT02774980</DOCNO>
	<brief_summary>Patients depression frequently treatment resistant . Clinical manifestation depression various , cognitive dysfunction commonly present . Many factor involve treatment resistance . As biological marker available , clinical marker could consider predict response antidepressive treatment . The aim study investigate relation cognitive change remission depressive symptom patient recurrent depression ( Stage 2 Thase Rush classification ) . To explore dynamic cognitive dimension associate clinical functional remission , investigator observe neurocognitive function introduce new antidepressive therapy .</brief_summary>
	<brief_title>Cognitive Markers Response Treatment Resistant Depression</brief_title>
	<detailed_description />
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<criteria>Patients age 40 70 , major depressive episode diagnosis 2 stage degree resistance . Patients major depressive episode 12 month Alzheimer dementia relate disease ( CIM 10 ) Score Hamilton Depression Rating Scale ( HDRS ) &lt; 18</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>May 2016</verification_date>
</DOC>